| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Crinetics Pharmaceuticals, Inc. (CRNX) has 11 insiders with recent SEC Form 4 filings, including 1 buy and 36 sells. CRNX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 223.2K | $18.73M | - | |
| Other | 147.7K | $12.40M | - | |
| COO | 121.9K | $10.23M | - | |
| CFO | 84.8K | $7.12M | - | |
| Other | 69.0K | $5.79M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 16, 2020 | Struthers Richard Scott54 | President &CEO | Sell | 35,000 | $14.88 | $520,829.75 | -1.9% | |
| Apr 17, 2020 | Perceptive Advisors LLC51 | 10% Owner | Buy | 1,071,428 | $14.00 | $14,999,992.00 | +41.4% | |
| Apr 17, 2020 | Vivo Capital Viii, LLC57 | 10% Owner | Sell | 330,598 | $15.45 | $5,106,752.20 | -4.2% | |
| Apr 7, 2020 | Vivo Capital Viii, LLC57 | 10% Owner | Sell | 306,115 | $13.81 | $4,226,833.00 | -5.2% | |
| Mar 9, 2020 | Vivo Capital Viii, LLC57 | 10% Owner | Sell | 528 | $19.50 | $10,296.00 | - | |
| Feb 10, 2020 | Vivo Capital Viii, LLC57 | 10% Owner | Sell | 13,460 | $21.66 | $291,587.00 | -0.2% | |
| Feb 4, 2020 | Vivo Capital Viii, LLC57 | 10% Owner | Sell | 13,460 | $22.80 | $306,888.00 | -0.4% | |
| Jan 31, 2020 | Vivo Capital Viii, LLC57 | 10% Owner | Sell | 26,920 | $22.07 | $594,164.00 | -0.3% | |
| Dec 16, 2019 | Fust Matthew K77 | Director | Sale+OE | 3,500 | $22.50 | $78,750.00 | -21.8% | |
| Jun 21, 2019 | 5am Ventures Iv, L.P. | Former 10% Holder | Sell | 250,000 | $22.20 | $5,550,000.00 | -9.6% |